-
Mashup Score: 500You and Whose Army? - 1 month(s) ago
The Oncologist is committed to helping physicians excel in the constantly changing fields of oncology and hematology through the publication of timely reviews, original studies, and commentaries on important developments.
Categories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 6The Oncologist - 4 month(s) ago
The Oncologist is committed to helping physicians excel in the constantly changing fields of oncology and hematology through the publication of timely reviews, original studies, and commentaries on important developments.
Categories: General Medicine News, Future of MedicineTweet-
“But we are here, alive and together.” Wow. Truly inspiring. ❤️ https://t.co/matvIm3if7 @realbowtiedoc @drdonsdizon #GIS24 https://t.co/o9YEDKu0mL
-
-
Mashup Score: 6The Oncologist - 4 month(s) ago
The Oncologist is committed to helping physicians excel in the constantly changing fields of oncology and hematology through the publication of timely reviews, original studies, and commentaries on important developments.
Categories: General Medicine News, Future of MedicineTweet-
“But we are here, alive and together.” Wow. Truly inspiring. ❤️ https://t.co/matvIm3if7 @realbowtiedoc @drdonsdizon #GIS24 https://t.co/o9YEDKu0mL
-
-
Mashup Score: 24Does Scalp Cooling Have the Same Efficacy in Black Patients Receiving Chemotherapy for Breast Cancer? - 3 year(s) ago
Christopher Gallagher, Princess Alintah, Ami Chitalia, Shruti Tiwari, Richard Paxman, Lucile Adams-Campbell, Chiranjeev Dash © AlphaMed Press; the data published online to support this summary are the property of the authors.https://doi.org/10.1002/onco.13690 Published inThe Oncologist PublisherJohn Wiley & Sons, Ltd eISSN1549-490X Received21…
Categories: Latest Headlines, Oncologists1Tweet-
🚨@Oncoalert Before a patient invests THOUSANDS OF DOLLARS in #scalpcooling, we should probably know if it works for them. I APPLAUD this study evaluating if Black pts w/ #breastCancer get the same benefit shown in clinical trials. Guess what? THEY DO NOT. https://t.co/VpatId1mnX https://t.co/ufrj4QqyVN
-
-
Mashup Score: 1Oncology Expanded Access and FDA's Project Facilitate - 3 year(s) ago
ARTICLE Oncology Expanded Access and FDA’s Project Facilitate Barbara Scepura, Mitchell Chan, Tamy Kim, Jessica Boehmer, Kirsten B. Goldberg, Richard Pazdur format_quote CITE Published 2021. This article is a U.S. Government work and is in the public domain in the USA.https://doi.org/10.1002/onco.13910 Published inThe Oncologist PublisherJohn…
Categories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Oncology Expanded Access and FDA's Project Facilitate - Learn how oncology healthcare providers can use Project Facilitate to help patients receive access to investigational medical products. @OncJournal #ExpandedAccess #ProjectFacilitate #OCEpublications https://t.co/NYYCrtmXqE https://t.co/7l4IjgtgjE
-
-
Mashup Score: 3Oncology Expanded Access and FDA’s Project Facilitate - 3 year(s) ago
ARTICLE Oncology Expanded Access and FDA’s Project Facilitate Barbara Scepura, Mitchell Chan, Tamy Kim, Jessica Boehmer, Kirsten B. Goldberg, Richard Pazdur format_quote CITE © AlphaMed Press 2021https://doi.org/10.1002/onco.13910 Published inThe Oncologist PublisherJohn Wiley & Sons, Inc. eISSN1549-490X …
Categories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Oncology Expanded Access and FDA's Project Facilitate - Learn how oncology healthcare providers can use Project Facilitate to help patients receive access to investigational medical products. @OncJournal #ExpandedAccess #ProjectFacilitate #OCEpublications https://t.co/NYYCrtmXqE
-
-
Mashup Score: 17Prognostic Factors for Overall Survival in Patients With Hormone Receptor–Positive Advanced Breast Cancer: Analyses From PALOMA‐3 - 3 year(s) ago
Massimo Cristofanilli, Sybille Loibl, Nadia Harbeck, Angela DeMichele, Hiroji Iwata, Yoon Hee Park, Adam Brufsky, Kathy Puyana Theall, Xin Huang, Lynn McRoy, Eustratios Bananis, Nicholas C. Turner AbstractBackground This analysis investigated whether baseline characteristics impact the survival benefit derived from palbociclib-fulvestrant, and the optimal timing of cyclin-dependent…
Categories: Hem/Oncs, Latest HeadlinesTweet-
Excited to share our new paper evaluating prognostic factors for OS in pts on PALOMA3. OS with no prior chemo; palbo vs placebo: 39.7 vs 29.5 mo; HR, 0.75; 95% CI:0.56–1.01. Sequential ET with CDK4/6i in 1st or 2nd line is SOC. https://t.co/nU1AsyVjbr @OncoAlert @UCSFCancer
-
-
Mashup Score: 9Personal Payments from Pharmaceutical Companies to Authors of Oncology Clinical Practice Guidelines - 3 year(s) ago
Akriti Mishra, Pranam Dey, Michael A. Curry, Niti U. Trivedi, Michael Haddadin, Mohammed W. Rahman, Aaron N. Winn, Stacie B. Dusetzina, Peter B. Bach AbstractBackground Oncologists who author clinical practice guidelines frequently have financial relationships with the pharmaceutical industry. It is unknown whether participation on clinical practice guideline committees is associated…
Categories: Hem/Oncs, Latest HeadlinesTweet-
https://t.co/0ZQaIsCXnN More COI = More likely to be invited on NCCN guidelines. What an unfortunate sequence of events. Status quo has gone on for too long! @TheWonkologist - Stellar work.
-
-
Mashup Score: 3Personal Payments from Pharmaceutical Companies to Authors of Oncology Clinical Practice Guidelines - 3 year(s) ago
Akriti Mishra, Pranam Dey, Michael A. Curry, Niti U. Trivedi, Michael Haddadin, Mohammed W. Rahman, Aaron N. Winn, Stacie B. Dusetzina, Peter B. Bach AbstractBackground Oncologists who author clinical practice guidelines frequently have financial relationships with the pharmaceutical industry. It is unknown whether participation on clinical practice guideline committees is associated…
Categories: Healthcare Professionals, Latest HeadlinesTweet-
Personal $$$ from Pharma Companies 2 Authors of Oncol' Clin Practice Guidelines https://t.co/gyL117DD9F via @TheWonkologist & @peterbachmd et al @susan_bewley @dr_benoy_n_shah @kidneydoc101 @DrAoifeMolloy @CatherineThomp8 @janewilcock @TomPMarshall @mancunianmedic @drtimwilson https://t.co/hpKkMTVPT3
-
-
Mashup Score: 1Remember Your Why… An Oncologist's Reflections on Running During the COVID‐19 Pandemic - 3 year(s) ago
info_outlinedNodes are locations in the document that facilitate reading from beginning to end. You can navigate node by node or select one to jump to.
Categories: Hem/Oncs, Latest HeadlinesTweet-
Sharing my piece, "Remember Your Why… An Oncologist’s Reflections on Running During the #COVID19 Pandemic." As @des_linden stated, “Remember your why. When things get hard you have the decision to bail or you can remember your why.” @BAA @bostonmarathon https://t.co/N39yySpp2s
-
Few things are as inevitable as the word “battle” appearing in the obituary for a patient who died of cancer But we need to reframe the disease in a manner that does not imply cowardice or ignobility for level-headed refusal of treatment https://t.co/wZ6NR8rDSq